In comparison, the proportions of patients who had high CD40 expression and low-moderate CD40L expression were 20% (4/20) in lung, 17% (4/24) in sarcoma, 16% (4/25) in stomach, 8% (2/24) in uterine, 8% (11/140) in colorectal, and 4% (2/49) in breast (Fig. 3B). This evidence concerns the gene CD40LG and sarcoma.